by | May 29, 2024 | Publications
Asian Pac J Cancer Prev. 2024 May 1;25(5):1599-1605. doi: 10.31557/APJCP.2024.25.5.1599. ABSTRACT BACKGROUND: Multiple myeloma (MM) is the second most prevalent blood cancer after non-Hodgkin lymphoma. It is identified by the excessive production of abnormal...
by | May 29, 2024 | Publications
Anthropol Anz. 2024 May 29. doi: 10.1127/anthranz/2024/1801. Online ahead of print. ABSTRACT The first archaeological case of multiple myeloma (MM) from historic period North America is presented. Only 49 cases of MM have been reported from archaeological contexts and...
by | May 29, 2024 | Publications
J Bras Pneumol. 2024 May 27;50(2):e20240080. doi: 10.36416/1806-3756/e20240080. NO ABSTRACT PMID:38808833 | DOI:10.36416/1806-3756/e20240080
by | May 29, 2024 | Publications
Blood Cancer J. 2024 May 28;14(1):86. doi: 10.1038/s41408-024-01067-x. ABSTRACT Multiple myeloma (MM) therapeutics have evolved tremendously in recent years, with significant improvement in patient outcomes. As newer treatment options are developed, stem cell...
by | May 29, 2024 | Publications
EJNMMI Res. 2024 May 28;14(1):51. doi: 10.1186/s13550-024-01113-6. ABSTRACT BACKGROUND: 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography combined with low-dose computed tomography (PET/CT) can be used at diagnosis to identify myeloma-defining...
by | May 29, 2024 | Publications
Vestn Otorinolaringol. 2024;89(2):82-87. doi: 10.17116/otorino20248902182. ABSTRACT This article describes a rare case of necrotic xanthogranuloma in a 46-year-old patient who presented with the development of periorbital xanthelasms, progressive bilateral...
